Graham Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,667
Closed -$1.06M 1047
2023
Q4
$1.06M Buy
3,667
+1,183
+48% +$322K 0.02% 378
2023
Q3
$668K Buy
2,484
+1,117
+82% +$279K 0.02% 480
2023
Q2
$304K Buy
+1,367
New +$317K 0.01% 678
2022
Q1
Sell
-1,007
Closed -$226K 885
2021
Q4
$226K Buy
+1,007
New +$213K 0.01% 422
2017
Q3
Sell
-7,500
Closed -$1.29M 57
2017
Q2
$1.29M Buy
+7,500
New +$1.22M 0.03% 41
2015
Q4
Sell
-8,100
Closed -$1.12M 53
2015
Q3
$1.12M Buy
8,100
+2,540
+46% +$400K 0.13% 87
2015
Q2
$854K Buy
5,560
+910
+20% +$146K 0.05% 102
2015
Q1
$743K Buy
+4,650
New +$732K 0.04% 103

Other funds holding AMGN

Graham Capital Management's AMGN Position: Q1 2024 in Review

Graham Capital Management sold out of Amgen (AMGN) in Q1 2024, closing a stake of 3,667 shares — an estimated $1.06M sold.

Graham Capital Management first reported a position in AMGN in Q1 2015 and held it in 8 quarters. The position peaked at $1.29M in Q2 2017. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Graham Capital Management reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Graham Capital Management sold 3,667 Amgen shares in Q1 2024, an estimated $1.06M.
  • Graham Capital Management first reported a position in Amgen in Q1 2015 and held it in 8 quarters.
  • Graham Capital Management's Amgen position peaked at $1.29M in Q2 2017.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Graham Capital Management's 13F filing for Q1 2024, filed 15 May 2024.